Islet

NatureLab-made islet cell implants sail through diabetes trials, but are they ready yet?First-in-human studies provide hope that islet replacement therapies derived from stem cells will prove safe and effective in people with….19 hours ago

NatureLab-made islet cell implants sail through diabetes trials, but are they ready yet?First-in-human studies provide hope that islet replacement therapies derived from stem cells will prove safe and effective in…

Read more

NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression

ZURICH, Jan. 12, 2026 /PRNewswire/ — NewcelX Ltd. (Nasdaq: NCEL) (“NewcelX” or the “Company”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today reported the results of an international collaborative research…

Read more

Savvy Update, 7/7/25: 3D printed islet transplantation, next-generation glucagon analog/therapy funded abvance therapy, ax-4 space mission research to prevent hypoS, conducting research on glucose metabolism and microgravity, assistive systems, FDA dialogue system implementation

This week's issue of The Savvy Diabetic: 3D printed islet transplantation Abvance therapy funded for next-generation glucagon analogs/therapies Glucotrack's CBGM Implant Technology The AX-4 Space Mission Study Glucose Metabolism and…

Read more

Wise Updates, January 13, 2025: Sana islet cell transplantation without immunosuppression, Beta Bionics Files IPO, Glooko/Hedia unveils D-management technology, Simple patch pump by CeQur $$, Sweat Blood Sugar Value Monitoring, Medical Debt Removal from Credit, Best Coffee in the Morning

Sana Biotechnology Announces Positive Clinical Results in Type 1 Diabetes Study of Pancreatic Islet Cell Transplantation Without Immunosuppression Released by Sana.com on January 7, 2025. Sana Biotechnology, Inc., a company…

Read more